FDA approves Claris’ anti-infective injectable

Indian drugmaker Claris Injectibles, a subsidiary of Claris Lifesciences Limited, earned Food and Drug Administration approval for its tobramycin injectable medication.

Advertisement

Tobramycin is an anti-infective used to treat serious bacterial infections, including meningitis and infections of the blood, abdomen, lungs, bone and urinary tract.

Claris currently has 14 drug approvals, with 24 pending. The company expects more market approvals later this year.

More articles on supply chain:

4 latest FDA approvals
Pfizer agrees to acknowledge addiction risks in opioid marketing
FDA approves safety device that prevents needle sticks

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.